Introduction to Market Access for Pharmaceuticals

<p>Market access is the fourth hurdle in the drug development process and the primary driver for global income of any new drug. Without a strategy in place for pricing showing value for effectiveness and an understanding of the target purchasers’ needs the drug will fail to reach its intended market value. <b><i>Introduction to Market Access for Pharmaceuticals</i></b> is based on an accredited course in this area taken from the European Market Access University Diploma (EMAUD) and is affiliated with Aix Marseille University.</p><p>Key Features:</p><li>The first guide to market access for pharmaceuticals based on tested teaching materials</li><li>Addresses both pharmaceutical and vaccine products</li><li>Includes case studies and scenarios</li><li>Covers market access consdierations for Western Europe the USA Japan and China</li><li>Explains the impact the changing healthcare market will have on your product</li>